Benjamin Edwards Inc’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.52M | Buy |
64,635
+9,643
| +18% | +$674K | 0.06% | 301 |
|
|
2025
Q1 | $4.04M | Sell |
54,992
-1,083
| -2% | -$79.6K | 0.06% | 289 |
|
|
2024
Q4 | $3.67M | Sell |
56,075
-3,796
| -6% | -$249K | 0.05% | 311 |
|
|
2024
Q3 | $4.66M | Buy |
59,871
+46,537
| +349% | +$3.63M | 0.07% | 271 |
|
|
2024
Q2 | $1.04M | Sell |
13,334
-1,534
| -10% | -$120K | 0.2% | 130 |
|
|
2024
Q1 | $1.01M | Buy |
14,868
+1
| +0% | +$68 | 0.2% | 131 |
|
|
2023
Q4 | $1M | Sell |
14,867
-6,769
| -31% | -$456K | 0.22% | 128 |
|
|
2023
Q3 | $1.47M | Buy |
21,636
+3,385
| +19% | +$229K | 0.35% | 87 |
|
|
2023
Q2 | $1.31M | Buy |
18,251
+342
| +2% | +$24.5K | 0.3% | 94 |
|
|
2023
Q1 | $1.24M | Sell |
17,909
-3,405
| -16% | -$236K | 0.3% | 93 |
|
|
2022
Q4 | $1.45M | Buy |
21,314
+2,727
| +15% | +$185K | 0.38% | 79 |
|
|
2022
Q3 | $1.02M | Buy |
18,587
+1,858
| +11% | +$102K | 0.31% | 100 |
|
|
2022
Q2 | $1.11M | Buy |
16,729
+2,304
| +16% | +$152K | 0.32% | 95 |
|
|
2022
Q1 | $957K | Buy |
14,425
+6,361
| +79% | +$422K | 0.28% | 108 |
|
|
2021
Q4 | $470K | Buy |
8,064
+7,086
| +725% | +$413K | 0.15% | 157 |
|
|
2021
Q3 | $59K | Buy |
978
+678
| +226% | +$40.9K | 0.04% | 281 |
|
|
2021
Q2 | $18K | Hold |
300
| – | – | 0.01% | 335 |
|
|
2021
Q1 | $15K | Hold |
300
| – | – | 0.01% | 316 |
|
|
2020
Q4 | $15K | Hold |
300
| – | – | 0.01% | 308 |
|
|
2020
Q3 | $16K | Hold |
300
| – | – | 0.01% | 292 |
|
|
2020
Q2 | $16K | Hold |
300
| – | – | 0.01% | 265 |
|
|
2020
Q1 | $13K | Buy |
+300
| New | +$13K | 0.01% | 265 |
|